Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin (Abstract)

Dijie Li; Hewen Jiang; Luyao Wang; Ning Zhang; Sifan Yu; Huarui Zhang; Nanxi LI; Jin Liu; Daqing Ma; Aiping Lu; Hui Sheng; Bao Ting Zhang; Ge Zhang

doi:10.1016/j.metabol.2023.155439

Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin (Abstract)

Dijie Li
, Hewen Jiang
, Luyao Wang
, Ning Zhang
, Sifan Yu
, Huarui Zhang
, Nanxi LI
, Jin Liu
, Daqing Ma
, Aiping Lu
, Hui Sheng^*
, Bao Ting Zhang^*
, Ge Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Conference article › peer-review

Original language	English
Article number	155439
Number of pages	1
Journal	Metabolism: Clinical and Experimental
Volume	142
Issue number	Supplement
DOIs	https://doi.org/10.1016/j.metabol.2023.155439
Publication status	Published - May 2023
Event	20th Annual World Congress on Insulin Resistance Diabetes & Cardiovascular Disease, WCIRDC 2022 - Los Angeles, United States Duration: 1 Dec 2022 → 3 Dec 2022 https://www.wcir.org/previous-abstracts (Previous conference abstracts)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

User-Defined Keywords

type 2 diabetes
lipid metabolism
glucose metabolism
sclerostin loop3

Access to Document

10.1016/j.metabol.2023.155439

Cite this

Li, D., Jiang, H., Wang, L., Zhang, N., Yu, S., Zhang, H., LI, N., Liu, J., Ma, D., Lu, A., Sheng, H., Zhang, B. T., & Zhang, G. (2023). Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin (Abstract). Metabolism: Clinical and Experimental, 142(Supplement), Article 155439. https://doi.org/10.1016/j.metabol.2023.155439

@article{26a83bf774d540138a0e849c00d3468a,

title = "Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin (Abstract)",

keywords = "type 2 diabetes, lipid metabolism, glucose metabolism, sclerostin loop3",

author = "Dijie Li and Hewen Jiang and Luyao Wang and Ning Zhang and Sifan Yu and Huarui Zhang and Nanxi LI and Jin Liu and Daqing Ma and Aiping Lu and Hui Sheng and Zhang, \{Bao Ting\} and Ge Zhang",

note = "Funding information: This work was supported by GRF (12100921, G.Z.), GDSTC (2019B1515120089, G.Z.) and TRS (T12-201/20-R, A.L.). The authors have declared that no competing interest exists.; 20th Annual World Congress on Insulin Resistance Diabetes \& Cardiovascular Disease, WCIRDC 2022 ; Conference date: 01-12-2022 Through 03-12-2022",

year = "2023",

month = may,

doi = "10.1016/j.metabol.2023.155439",

language = "English",

volume = "142",

journal = "Metabolism: Clinical and Experimental",

issn = "0026-0495",

publisher = "W.B. Saunders",

number = "Supplement",

url = "https://www.wcir.org/previous-abstracts",

}

TY - JOUR

T1 - Sclerostin Loop3 Participates in Whole-body Lipid and Glucose Metabolism Impairment Effects of Sclerostin (Abstract)

AU - Li, Dijie

AU - Jiang, Hewen

AU - Wang, Luyao

AU - Zhang, Ning

AU - Yu, Sifan

AU - Zhang, Huarui

AU - LI, Nanxi

AU - Liu, Jin

AU - Ma, Daqing

AU - Lu, Aiping

AU - Sheng, Hui

AU - Zhang, Bao Ting

AU - Zhang, Ge

N1 - Funding information: This work was supported by GRF (12100921, G.Z.), GDSTC (2019B1515120089, G.Z.) and TRS (T12-201/20-R, A.L.). The authors have declared that no competing interest exists.

PY - 2023/5

Y1 - 2023/5

KW - type 2 diabetes

KW - lipid metabolism

KW - glucose metabolism

KW - sclerostin loop3

U2 - 10.1016/j.metabol.2023.155439

DO - 10.1016/j.metabol.2023.155439

M3 - Conference article

SN - 0026-0495

VL - 142

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

IS - Supplement

M1 - 155439

T2 - 20th Annual World Congress on Insulin Resistance Diabetes & Cardiovascular Disease, WCIRDC 2022

Y2 - 1 December 2022 through 3 December 2022

ER -